Find a Trial

Trial Summary


Protocol No.PHO-TAKEDA-PON1501-AALL1922
StatusOPEN TO ACCRUAL
Principal InvestigatorBatra, Sandeep
ScopeNational
PhasePhase I/II
Age GroupChildren
TitleA Pivotal Phase 1/2, Single-Arm, Open-label Study to Evaluate the Safety and Efficacy of Ponatinib With Chemotherapy in Pediatric Patients With Philadelphia Chromosome-Positive (Ph+) Acute Lymphoblastic Leukemia (ALL) Who Have Relapsed or Are Resistant or Intolerant to a Prior Tyrosine Kinase Inhibitor-Containing Therapy, or Who Have the T315I Mutation
Applicable Disease SitesLeukemia, other
Participating InstitutionsIU Health North Hospital
    Indiana University (IU)
      Treatment TypeTreatment
      ContactFernanda C. Rankin, Phone:
      Pager:
      Email: fecarnev@iu.edu